Updated outcomes with axicabtagene ciloleucel (axi-cel) retreatment (reTx) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) in ZUMA-5 Meeting Abstract
| Authors: | Chavez, J. C.; Jacobson, C. A.; Sehgal, A.; Neelapu, S. S.; Maloney, D. G.; Salles, G. A.; William, B. M.; Yang, Y.; Goyal, L.; Chou, J.; Plaks, V.; Avanzi, M. P. |
| Abstract Title: | Updated outcomes with axicabtagene ciloleucel (axi-cel) retreatment (reTx) in patients (pts) with relapsed/refractory (R/R) indolent non-Hodgkin lymphoma (iNHL) in ZUMA-5 |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120604145 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.7548 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 7548 -- Source: Wos |
